Researchers show that certain antibio... - Lung Conditions C...

Lung Conditions Community Forum

55,874 members66,527 posts

Researchers show that certain antibiotics can prevent the entry of SARS-CoV-2 into cells.

2greys profile image
11 Replies

The Drug Design and Molecular Topology Unit group of the University of Valencia has shown that certain macrolide antibiotics (used in respiratory tract infections), including clarithromycin and azithromycin, can prevent the entry of SARS-CoV -2 in cells. The study, led by Professor of Physical Chemistry Jorge Gálvez, has been published in the prestigious North American Journal of Chemical Information and Modeling.J. Galvez and his research team

The group already pioneered an article in March 2020, proposing such antibiotics as drugs that could be targeted to treat COVID-19. However, this prediction was only based on theoretical computational calculations. The method was based on molecular topology, a part of mathematical chemistry that deals with the algebraic description of chemical compounds, which allows them to be easily characterised.

Now, in collaboration with researchers from the National Center for Biotechnology (CSIC), they have shown with their study that these antibiotics are capable of preventing the entry of the virus in vitro by deactivating the well-known spike protein.

ruvid.org/ri-world/research...

Journal of Chemical Information and Modelling. Research Paper:

pubs.acs.org/doi/10.1021/ac...

Written by
2greys profile image
2greys
To view profiles and participate in discussions please or .
Read more about...
11 Replies
sassy59 profile image
sassy59

Wow, great news. Xxxx

cofdrop-UK profile image
cofdrop-UK

Excellent post 2g. Shame I cannot tolerate macrolides but preferable to covid.

Thank you.

Cx

Very interesting

2greys profile image
2greys

Not yet, if they do, I will direct them to take up any argument with the researchers at the University of Valencia, I am not a member of that faculty either. 🤪

hypercat54 profile image
hypercat54 in reply to 2greys

😁😂🤣 x

Oshgosh profile image
Oshgosh in reply to 2greys

🥂💥💥💥

Oshgosh profile image
Oshgosh

That’s really interesting and potentially encouraging.I e been on Azithromycin for over 2 years.thanks for that.

Jandm profile image
Jandm

My consultant told me about that theory last year, so that’s fantastic news 😃

santisuk profile image
santisuk

Same as Oshgosh. 3 x a week prophylactic dose for my bronchX. No infections for nearly 2 years. I love my azith! Hope the research doesn't lead to a sudden shortage. I'd better stock up.

Coincidentally my pharmacist told me yesterday that my other bronchx drug - the mucolytic NAC acetylcysteine - is making a showing as a potential Covid symptom reliever in consort with hydrocloxychloroquin. I was buying 4 months supply of that anyway! I had told him in response that I'd read that azith was being rumoured as a helper too (based on something I'd seen a month back.

Now I write that I can't recall whether it's the azith or the acetylcysteine that goes with hydro-thingy.

ElsaC profile image
ElsaC

Good to know.

Patk1 profile image
Patk1

Unfortunately I still got covid last mar/Apr whilst on azithromycin 250mg x2 daily

Not what you're looking for?

You may also like...

Immunological memory after SARS-CoV-2 infection recovery. *The welcome news we have been waiting for*

Until now, it was unclear whether a survived SARS-CoV-2 infection or COVID-19 leads to a persistent...

Discovery of a druggable pocket in the SARS-CoV-2 Spike protein could stop virus in its tracks.

A druggable pocket in the SARS-CoV-2 Spike protein that could be used to stop the virus from...

‘Mini-lungs’ reveal early stages of SARS-CoV-2 infection

‘Mini-lungs’ grown from tissue donated to Cambridge hospitals has provided a team of scientists...

How Long the COVID-19 Virus Lasts on Surfaces: New Research on SARS-CoV-2 “Survivability”.

Researchers at CSIRO, Australia’s national science agency, have found that SARS-CoV-2, the virus...

Most People Mount a Strong Antibody Response to SARS-CoV-2 That Does Not Decline Rapidly.

The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody...